313 related articles for article (PubMed ID: 18374723)
1. Focal nodular hyperplasia: typical and atypical MRI findings with emphasis on the use of contrast media.
Marin D; Brancatelli G; Federle MP; Lagalla R; Catalano C; Passariello R; Midiri M; Vilgrain V
Clin Radiol; 2008 May; 63(5):577-85. PubMed ID: 18374723
[TBL] [Abstract][Full Text] [Related]
2. Magnetic resonance imaging of focal liver lesions: approach to imaging diagnosis.
Fowler KJ; Brown JJ; Narra VR
Hepatology; 2011 Dec; 54(6):2227-37. PubMed ID: 21932400
[TBL] [Abstract][Full Text] [Related]
3. Hepatocyte-specific magnetic resonance imaging contrast agents.
Fidler J; Hough D
Hepatology; 2011 Feb; 53(2):678-82. PubMed ID: 21274888
[No Abstract] [Full Text] [Related]
4. [Gd-EOB-DTPA-enhanced magnetic resonance imaging: differentiation between focal nodular hyperplasia and hepatocellular adenoma].
Portilha MA; Pedro MT; Ruivo C; Semedo LC; Marques C; Alves FC
Acta Med Port; 2011 Dec; 24 Suppl 2():531-8. PubMed ID: 22849944
[TBL] [Abstract][Full Text] [Related]
5. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI.
Finley AC; Hosey JR; Noone TC; Shackelford DM; Varadarajulu S
Magn Reson Imaging; 2005 Apr; 23(3):511-3. PubMed ID: 15862653
[TBL] [Abstract][Full Text] [Related]
6. [Differentiation of focal liver lesions using contrast-enhanced MRT].
Heintz P; Ehrenheim C
Rofo; 1989 Mar; 150(3):297-306. PubMed ID: 2538880
[TBL] [Abstract][Full Text] [Related]
7. Diagnosis of focal nodular hyperplasia with MRI: multicenter retrospective study comparing gadobenate dimeglumine to gadoxetate disodium.
Gupta RT; Iseman CM; Leyendecker JR; Shyknevsky I; Merkle EM; Taouli B
AJR Am J Roentgenol; 2012 Jul; 199(1):35-43. PubMed ID: 22733891
[TBL] [Abstract][Full Text] [Related]
8. Magnetic resonance imaging of liver lesions: exceptions and atypical lesions.
van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Preda A; Krestin GP
Curr Probl Diagn Radiol; 2008; 37(3):95-103. PubMed ID: 18436109
[TBL] [Abstract][Full Text] [Related]
9. Magnetic resonance imaging findings of atypical focal nodular hyperplasia of the liver.
Asbach P; Klessen C; Koch M; Hamm B; Taupitz M
Clin Imaging; 2007; 31(4):244-52. PubMed ID: 17599618
[TBL] [Abstract][Full Text] [Related]
10. Primary hepatocellular lesions: imaging findings on state-of-the-art magnetic resonance imaging, with pathologic correlation.
van den Bos IC; Hussain SM; de Man RA; Zondervan PE; Ijzermans JN; Krestin GP
Curr Probl Diagn Radiol; 2008; 37(3):104-14. PubMed ID: 18436110
[TBL] [Abstract][Full Text] [Related]
11. [Dynamic MRI of the liver with parallel acquisition technique: characterization of focal liver lesions and analysis of the hepatic vasculature in a single MRI session].
Heilmaier C; Sutter R; Lutz AM; Seifert B; Willmann JK
Rofo; 2008 May; 180(5):440-8. PubMed ID: 18438745
[TBL] [Abstract][Full Text] [Related]
12. The role of ADC measurement in differential diagnosis of focal hepatic lesions.
Onur MR; Çiçekçi M; Kayalı A; Poyraz AK; Kocakoç E
Eur J Radiol; 2012 Mar; 81(3):e171-6. PubMed ID: 21353418
[TBL] [Abstract][Full Text] [Related]
13. MultiHance: help or hype?
Bartolozzi C; Spinazzi A
J Comput Assist Tomogr; 1999 Nov; 23 Suppl 1():S151-9. PubMed ID: 10608411
[TBL] [Abstract][Full Text] [Related]
14. Liver lesion characterization: the wrong choice of contrast agent can mislead the diagnosis of hemangioma.
Pradella S; Lucarini S; Colagrande S
AJR Am J Roentgenol; 2012 Nov; 199(5):W662. PubMed ID: 23096214
[No Abstract] [Full Text] [Related]
15. Focal nodular hyperplasia on MRI using a hepatocyte-specific contrast agent at 1.5 Tesla vs. 3.0 Tesla field strength.
Chang KJ
Med Health R I; 2012 Feb; 95(2):43-5. PubMed ID: 22474873
[No Abstract] [Full Text] [Related]
16. Magnetic resonance imaging of hepatocellular carcinoma mimicking focal nodular hyperplasia: a potential pitfall in patients with cirrhosis?
Rafaelian O; Coakley FV; Qayyum A; Breiman RS; Yeh BM; Joe BN; Westphalen AC; Feng S
J Comput Assist Tomogr; 2006; 30(5):796-9. PubMed ID: 16954932
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic challenges and pitfalls in MR imaging with hepatocyte-specific contrast agents.
Goodwin MD; Dobson JE; Sirlin CB; Lim BG; Stella DL
Radiographics; 2011 Oct; 31(6):1547-68. PubMed ID: 21997981
[TBL] [Abstract][Full Text] [Related]
18. MRI findings of hepatocellular carcinoma.
Wiwanitkit V
Magn Reson Imaging; 2011 Feb; 29(2):303. PubMed ID: 21129874
[No Abstract] [Full Text] [Related]
19. Focal nodular hyperplasia: central scar enhancement pattern using Gadoxetate Disodium.
Karam AR; Shankar S; Surapaneni P; Kim YH; Hussain S
J Magn Reson Imaging; 2010 Aug; 32(2):341-4. PubMed ID: 20677260
[TBL] [Abstract][Full Text] [Related]
20. MRI contrast agents for evaluating focal hepatic lesions.
Harisinghani MG; Jhaveri KS; Weissleder R; Schima W; Saini S; Hahn PF; Mueller PR
Clin Radiol; 2001 Sep; 56(9):714-25. PubMed ID: 11585393
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
